Izinova

Magnesium sulfate, sodium sulfate, potassium sulfate, the active ingredient in Izinova, is a mineral supplement presented as an oral formulation for oral use. It helps restore electrolyte balance and may be used in conditions requiring mineral supplementation.

GNH USA supplies Izinova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Izinova provides mineral salts that support electrolyte homeostasis and osmotic activity in the gastrointestinal tract.

- Electrolyte replenishment: restores magnesium, sodium and potassium levels in patients with deficiency or loss due to illness or treatment. - Constipation relief: the osmotic action of sulfate salts draws water into the bowel, facilitating stool passage. - Prevention of hypomagnesemia: supplies magnesium to reduce risk of muscle cramps and cardiac arrhythmias in at‑risk individuals.

Izinova may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal cramping: discomfort due to osmotic activity. - Diarrhea: loose stools from increased intestinal water. - Headache: occasional mild headache. - Dizziness: transient light‑headedness. - Metallic taste: brief aftertaste.

Serious or Rare Side Effects: - Hypermagnesemia: elevated magnesium levels causing muscle weakness or cardiac effects. - Hyperkalemia: excess potassium leading to arrhythmias. - Severe electrolyte imbalance: significant shifts in sodium or potassium. - Anaphylactic reaction: rare allergic response with rash, swelling, or breathing difficulty. - Severe hypotension: marked drop in blood pressure. - Acute renal failure: in patients with pre‑existing kidney disease.

When considering Izinova, clinicians should evaluate patient-specific factors and monitor for safety. - Assess baseline electrolyte levels: ensure magnesium, sodium and potassium are within normal range before initiation. - Monitor renal function: impaired kidneys may reduce clearance of the salts. - Avoid in severe renal impairment: risk of accumulation and toxicity. - Use caution with cardiac conduction disorders: electrolyte shifts can affect rhythm. - Do not combine with other osmotic laxatives: may cause excessive fluid loss. - Store at ambient temperature: keep in the original pack, protect from moisture.

Izinova can interact with several medicines that affect electrolyte balance or neuromuscular transmission.

Major Interactions (Avoid): - Neuromuscular blocking agents: potentiates muscle relaxation. - Calcium channel blockers: additive hypotensive effect. - Tetracycline antibiotics: reduced absorption of the antibiotic. - Potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors: may enhance potassium retention.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte loss. - Other mineral supplements: monitor total intake to avoid excess. - Antacids containing aluminum or magnesium: possible additive gastrointestinal effects. - NSAIDs: may affect renal handling of electrolytes. - Oral contraceptives: monitor for altered potassium levels.